Altamira Therapeutics Ltd. Increase Decrease In Net Defined Benefit Liability Asset Resulting From Administration Costs Not Reflected In Return On Plan Assets
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease In Net Defined Benefit Liability Asset Resulting From Administration Costs Not Reflected In Return On Plan Assets of -$4.84 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromAdministrationCostsNotReflectedInReturnOnPlanAssets · last filed 2025-04-30
| Period end | Increase Decrease In Net Defined Benefit Liability Asset Resulting From Administration Costs Not Reflected In Return On Plan Assets 12 month |
|---|---|
| 2024-12-31 | -$4.84K 20-F · filed 2025-04-30 |
| 2023-12-31 | -$5.60K 20-F · filed 2025-04-30 |